2025 was a year of growth, innovation, and global impact for Anatolia. We advanced our deep-rooted expertise in diagnostics through new product groups, strategic markets, and strong collaborations. As we enter 2026, we do so with a strong commitment to deepening our product portfolio, maximizing our R&D capabilities, and responding rapidly to global healthcare needs.
15 Years of Scientific Journey
This year, we proudly celebrated Anatolia’s 15th anniversary together with all our employees. What began with a team of five people in a 100 m² space has grown into a global biotechnology force with over 200 employees, 6 subsidiaries, and facilities exceeding 15,000 m².
Global Quality and IVDR Leadership
After becoming Türkiye’s first IVDR-certified molecular diagnostics manufacturer in 2024, we continued to expand the scope of our IVDR-certified products in 2025. Alongside IVDR, our internationally recognized quality certifications reflect our commitment to world-class manufacturing discipline and reliability.
Strategic
R&D Expansion
Our new R&D facility, covering about 600 m², became operational this year. With this expansion, we increased our Rapid Antigen Test Kits production capacity and sped up our R&D activities in new areas.
UNIO 448 and Future Technologies
We successfully launched UNIO 448, our new system that fully automates the workflow from sample to result. With additional instruments planned to enter production in 2026, we will continue to expand our technology portfolio.
Global Markets and a Growing Team
In 2025, we expanded into 12 new countries, bringing our total export reach to 96 countries worldwide. We also continued to grow our team with the addition of 38 new colleagues.
At Anatolia, we not only develop technology but also actively contribute to the dissemination of knowledge and solutions for global health challenges. Throughout 2025, we showcased our innovations at leading international exhibitions and supported sector development through in-house training and strategic meetings.
Global Congresses and Launches
ESCMID Global 2025
In addition to welcoming visitors at our booth, we organized a presentation titled “Microbiological Diagnosis of Sepsis,” evaluating different diagnostic approaches in sepsis and antimicrobial resistance, and sharing project results obtained using Bosphore kits.
Global Etkinlikler
From Chile to Gaziantep, across a wide geographical range, we participated in numerous congresses and exhibitions together with our RhineGene and Alpha teams, presenting solutions tailored to local market needs.
MEDICA & KLİMUD
We held the global launch of our next-generation fully automated system, UNIO 448, in Düsseldorf at MEDICA, followed by its local launch in Antalya during KLİMUD.
Training Programs and Strategic Meetings
Microbiology and Food Safety Workshops
Through theoretical and hands-on training programs hosted at our facilities, we contributed to strengthening experts’ competencies in molecular diagnostic techniques.
TR.AQUA
Project
As one of the program-executing organizations, we hosted TR.AQUA Project Second-Year Evaluation Meeting and discussed the molecular diagnosis of waterborne pathogens on the “Deep Blue Conversations” radio program.
We remain committed to delivering stronger responses to global healthcare needs through innovative diagnostic solutions and sustained R&D-driven growth.
We sincerely thank all our shareholders, business partners, and team members who made this successful year possible.
